Immunization, Vaccines and Biologicals
The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy.
Monitoring and Surveillance of HPV Vaccination Programmes
As HPV vaccine is recommended for an age group not routinely served by immunization programmes, and since the population impact of the vaccine on cervical cancer cannot be measured until years after the vaccine has been introduced, new approaches to monitoring coverage and impact are needed for HPV vaccine.
This section provides practical tools to keep track of and analyse programme results to continually monitor the effectiveness of HPV vaccine introduction and revise delivery strategies.
This section provides practical tools to keep track of and analyse programme results to continually monitor the effectiveness of HPV vaccine introduction and revise delivery strategies.
Publications
20 November 2019
Report of the meeting on HPV Vaccine Coverage and Impact Monitoring
A meeting on HPV Vaccine Coverage and Impact Monitoring was held at the World Health Organization (WHO) in Geneva, Switzerland on 16-17 November 2009 to...
An EPI Review, also referred to as National Immunization Programme Review, is the comprehensive assessment of the strengths and weaknesses of an immunization...
Human papillomaviruses (HPV) are the most common sexually transmitted infection. Although the majority of infections do not cause illness, persistent...
Evaluation tools
Resources
HPV introduction - technical resources
This toolbox on the TechNet-21 website contains practical tools often developed by EPI programmes and partners and is regularly updated.
